{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T20:35:35Z","timestamp":1792442135092,"version":"4.5.0"},"reference-count":198,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T00:00:00Z","timestamp":1632873600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: CardioOncology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.jaccao.2021.08.011","type":"journal-article","created":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T16:33:07Z","timestamp":1637080387000},"page":"619-634","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":128,"title":["Common Pathophysiology in Cancer, Atrial Fibrillation, Atherosclerosis, and Thrombosis"],"prefix":"10.1016","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3006-6380","authenticated-orcid":false,"given":"Orly","family":"Leiva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duaa","family":"AbdelHameid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean M.","family":"Connors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher P.","family":"Cannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak L.","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaccao.2021.08.011_bib1","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0140-6736(19)32007-0","article-title":"Variations in common diseases, hospital admissions, and deaths in middle-aged adults in 21\u00a0countries from five continents (PURE): a prospective cohort study","volume":"395","author":"Dagenais","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jaccao.2021.08.011_bib2","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1056\/NEJMoa1916623","article-title":"The effect of advances in lung-cancer treatment on population mortality","volume":"383","author":"Howlader","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaccao.2021.08.011_bib3","first-page":"7","article-title":"Cancer statistics 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jaccao.2021.08.011_bib4","first-page":"48","article-title":"Cardiovascular risk factors are associated with future cancer","volume":"3","author":"Lau","year":"2021","journal-title":"J\u00a0Am Coll Cardiol CardioOnc"},{"key":"10.1016\/j.jaccao.2021.08.011_bib5","first-page":"114","article-title":"Birth and maturation of cardio-oncology","volume":"1","author":"Bhatt","year":"2019","journal-title":"J\u00a0Am Coll Cardiol CardioOnc"},{"key":"10.1016\/j.jaccao.2021.08.011_bib6","first-page":"6S8","article-title":"Cancer and thrombosis: new insights to\u00a0an old problem","volume":"45","author":"Leiva","year":"2020","journal-title":"J\u00a0Med Vasc"},{"key":"10.1016\/j.jaccao.2021.08.011_bib7","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ijcard.2012.08.036","article-title":"Incident thromboembolism and heart failure associated with new-onset atrial fibrillation in cancer patients","volume":"165","author":"Hu","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jaccao.2021.08.011_bib8","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.jacc.2017.06.047","article-title":"Risk of arterial thromboembolism in patients with cancer","volume":"70","author":"Navi","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jaccao.2021.08.011_bib9","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1161\/CIR.0000000000000665","volume":"140","author":"January","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jaccao.2021.08.011_bib10","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jacc.2016.03.513","article-title":"2016 ACC\/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"68","author":"Levine","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jaccao.2021.08.011_bib11","article-title":"Extended duration of dual-antiplatelet therapy after percutaneous coronary intervention: how long is too long?","volume":"8","author":"Howard","year":"2019","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jaccao.2021.08.011_bib12","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.jaccao.2021.08.011_bib13","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nrcardio.2015.2","article-title":"Inflammation and the pathogenesis of atrial fibrillation","volume":"12","author":"Hu","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jaccao.2021.08.011_bib14","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.amjcard.2009.02.053","article-title":"Relation of multiple inflammatory biomarkers to incident atrial fibrillation","volume":"104","author":"Schnabel","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jaccao.2021.08.011_bib15","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1093\/eurheartj\/ehq146","article-title":"A\u00a0multimarker approach to assess the influence of inflammation on the incidence of atrial fibrillation in women","volume":"31","author":"Conen","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jaccao.2021.08.011_bib16","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJM199704033361401","article-title":"Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men","volume":"336","author":"Ridker","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaccao.2021.08.011_bib17","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJM200003233421202","article-title":"C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women","volume":"342","author":"Ridker","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaccao.2021.08.011_bib18","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1186\/s12872-020-01711-x","article-title":"C-reactive protein for prediction of atrial fibrillation recurrence after catheter ablation","volume":"20","author":"Meyre","year":"2020","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.jaccao.2021.08.011_bib19","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1161\/CIRCULATIONAHA.118.035202","article-title":"Enhanced cardiomyocyte NLRP3 inflammasome signaling promotes atrial fibrillation","volume":"138","author":"Yao","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jaccao.2021.08.011_bib20","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.jacc.2005.12.038","article-title":"Decline in C-reactive protein after successful ablation of long-lasting persistent atrial fibrillation","volume":"47","author":"Rotter","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jaccao.2021.08.011_bib21","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJM199408183310701","article-title":"The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina","volume":"331","author":"Liuzzo","year":"1994","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaccao.2021.08.011_bib22","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1161\/CIRCULATIONAHA.117.032636","article-title":"Cholesterol efflux pathways suppress inflammasome activation, NETosis, and atherogenesis","volume":"138","author":"Westerterp","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jaccao.2021.08.011_bib23","first-page":"2072","article-title":"Interleukin-1\u03b2 mediates arterial thrombus formation via NET-associated tissue factor","volume":"8","author":"Liberale","year":"2019","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.jaccao.2021.08.011_bib24","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.jacc.2016.12.033","article-title":"Association between rheumatoid arthritis and risk of ischemic and nonischemic heart failure","volume":"69","author":"Mantel","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jaccao.2021.08.011_bib25","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s13075-015-0728-9","article-title":"Incidence of malignancy in adult patients with rheumatoid arthritis: a meta-analysis","volume":"17","author":"Simon","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jaccao.2021.08.011_bib26","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaccao.2021.08.011_bib27","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/j.jacc.2020.08.011","article-title":"Inhibition of interleukin-1\u03b2 and reduction in atherothrombotic cardiovascular events in the CANTOS trial","volume":"76","author":"Everett","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jaccao.2021.08.011_bib28","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in patients with chronic coronary disease","volume":"383","author":"Nidorf","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaccao.2021.08.011_bib29","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaccao.2021.08.011_bib30","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/S0140-6736(17)32247-X","article-title":"Effect of interleukin-1\u03b2 inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial","volume":"390","author":"Ridker","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jaccao.2021.08.011_bib31","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/s41568-020-0285-7","article-title":"The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy","volume":"20","author":"Bruni","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jaccao.2021.08.011_bib32","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2000915118","article-title":"Targeting tumor-derived NLRP3 reduces melanoma progression by limiting MDSCs expansion","volume":"118","author":"Tengesdal","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaccao.2021.08.011_bib33","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3390\/cancers13030477","article-title":"Therapeutic strategies for targeting IL-1 in cancer","volume":"13","author":"Gottschlich","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jaccao.2021.08.011_bib34","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/s41568-021-00363-z","article-title":"Interleukins in cancer: from biology to therapy","volume":"21","author":"Briukhovetska","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jaccao.2021.08.011_bib35","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.ccr.2008.10.011","article-title":"Overexpression of interleukin-1\u03b2 induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice","volume":"14","author":"Tu","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jaccao.2021.08.011_bib36","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.immuni.2019.03.012","article-title":"Interleukin-1 and related cytokines in the regulation of inflammation and immunity","volume":"50","author":"Mantovani","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.jaccao.2021.08.011_bib37","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41568-018-0090-8","article-title":"Therapeutically exploiting STAT3 activity in cancer\u2014using tissue repair as a road map","volume":"19","author":"Huynh","year":"2019","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jaccao.2021.08.011_bib38","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1053\/j.gastro.2019.12.010","article-title":"Interleukin 22 signaling regulates acinar cell plasticity to promote pancreatic tumor development in mice","volume":"158","author":"Perusina Lanfranca","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaccao.2021.08.011_bib39","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/ajh.24352","article-title":"Reduction in C-reactive protein indicates successful targeting of the IL-1\/IL-6 axis resulting in improved survival in early stage multiple myeloma","volume":"91","author":"Lust","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jaccao.2021.08.011_bib40","doi-asserted-by":"crossref","first-page":"114","DOI":"10.4065\/84.2.114","article-title":"Induction of a chronic disease state in patients with smoldering or indolent multiple myeloma by targeting interleukin 1\u03b2-induced interleukin 6 production and the myeloma proliferative component","volume":"84","author":"Lust","year":"2009","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jaccao.2021.08.011_bib41","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1111\/jgh.15307","article-title":"Targeting interleukin 6 signaling by monoclonal antibody siltuximab on cholangiocarcinoma","volume":"36","author":"Nguyen","year":"2021","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jaccao.2021.08.011_bib42","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000001570","article-title":"Colchicine significantly reduces incident cancer in gout male patients: a 12-year cohort study","volume":"94","author":"Kuo","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jaccao.2021.08.011_bib43","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.semcdb.2017.05.023","article-title":"ROS signalling in the biology of cancer","volume":"80","author":"Moloney","year":"2018","journal-title":"Semin Cell Dev Biol"},{"key":"10.1016\/j.jaccao.2021.08.011_bib44","doi-asserted-by":"crossref","first-page":"9348","DOI":"10.1074\/jbc.M113.510495","article-title":"NADPH oxidase-generated hydrogen peroxide induces DNA damage in mutant FLT3-expressing leukemia cells","volume":"290","author":"Stanicka","year":"2015","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jaccao.2021.08.011_bib45","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/nm.2124","article-title":"Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation","volume":"16","author":"Rudolph","year":"2010","journal-title":"Nat Med"},{"key":"10.1016\/j.jaccao.2021.08.011_bib46","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3389\/fphys.2012.00214","article-title":"Fibrosis in atrial fibrillation\u2014role of reactive species and MPO","volume":"3","author":"Friedrichs","year":"2012","journal-title":"Front Physiol"},{"key":"10.1016\/j.jaccao.2021.08.011_bib47","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1365-2796.2004.01373.x","article-title":"Oxidative stress and its association with coronary artery disease and different atherogenic risk factors","volume":"256","author":"Vassalle","year":"2004","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.jaccao.2021.08.011_bib48","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1080\/10715760500539154","article-title":"Plasma 8-iso-prostaglandin F2\u03b1, a marker of oxidative stress, is increased in patients with acute myocardial infarction","volume":"40","author":"Elesber","year":"2006","journal-title":"Free Radic Res"},{"key":"10.1016\/j.jaccao.2021.08.011_bib49","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1161\/01.ATV.0000150649.39934.13","article-title":"Oxidative stress and vascular disease","volume":"25","author":"Madamanchi","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jaccao.2021.08.011_bib50","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/europace\/euq350","article-title":"Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)","volume":"12","author":"Camm","year":"2010","journal-title":"Europace"},{"key":"10.1016\/j.jaccao.2021.08.011_bib51","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1093\/eurheartj\/ehi825","article-title":"Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study","volume":"27","author":"Heeringa","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jaccao.2021.08.011_bib52","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12916-019-1474-7","article-title":"Lifestyle factors and risk of multimorbidity of cancer and cardiometabolic diseases: a multinational cohort study","volume":"18","author":"Freisling","year":"2020","journal-title":"BMC Med"},{"key":"10.1016\/j.jaccao.2021.08.011_bib53","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1634\/theoncologist.2009-0285","article-title":"Obesity and cancer","volume":"15","author":"Wolin","year":"2010","journal-title":"Oncologist"},{"key":"10.1016\/j.jaccao.2021.08.011_bib54","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jacc.2019.11.044","article-title":"Cardiometabolic-based chronic disease, adiposity and dysglycemia drivers: JACC state-of-the-art review","volume":"75","author":"Mechanick","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jaccao.2021.08.011_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0205454","article-title":"Cancer increases the risk of atrial fibrillation during long-term follow-up (OPERA study)","volume":"13","author":"Kattelus","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jaccao.2021.08.011_bib56","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1186\/s12885-019-6314-9","article-title":"Incidence of atrial fibrillation in different major cancer subtypes: a nationwide population-based 12 year follow up study","volume":"19","author":"Jakobsen","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jaccao.2021.08.011_bib57","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.hrthm.2018.10.017","article-title":"Incidence of atrial fibrillation in conjunction with breast cancer","volume":"16","author":"D\u2019Souza","year":"2019","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jaccao.2021.08.011_bib58","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1001\/jamacardio.2016.0280","article-title":"Risk of malignant cancer among women with new-onset atrial fibrillation","volume":"1","author":"Conen","year":"2016","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jaccao.2021.08.011_bib59","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0102861","article-title":"Atrial fibrillation as a marker of occult cancer","volume":"9","author":"Ostenfeld","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jaccao.2021.08.011_bib60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0190324","article-title":"Association of atrial fibrillation and cancer: Analysis from two large population-based case-control studies","volume":"13","author":"Saliba","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jaccao.2021.08.011_bib61","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ijcard.2016.06.009","article-title":"Pathophysiology of cancer therapy-provoked atrial fibrillation","volume":"219","author":"Cheng","year":"2016","journal-title":"Int J Cardiol"},{"issue":"suppl 1","key":"10.1016\/j.jaccao.2021.08.011_bib62","first-page":"S120","article-title":"Prevalence and predictors of new-onset atrial fibrillation after elective surgery for colorectal cancer","volume":"28","author":"Siu","year":"2005","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.jaccao.2021.08.011_bib63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0216239","article-title":"Incidence and complications of perioperative atrial fibrillation after non-cardiac surgery for malignancy","volume":"14","author":"Higuchi","year":"2019","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jaccao.2021.08.011_bib64","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/SLA.0000000000001626","article-title":"Prevention of atrial fibrillation in high-risk patients undergoing lung cancer surgery: the PRESAGE trial","volume":"264","author":"Cardinale","year":"2016","journal-title":"Ann Surg"},{"key":"10.1016\/j.jaccao.2021.08.011_bib65","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.ahj.2013.03.020","article-title":"Atrial fibrillation among Medicare beneficiaries hospitalized with sepsis: incidence and risk factors","volume":"165","author":"Walkey","year":"2013","journal-title":"Am Heart J"},{"key":"10.1016\/j.jaccao.2021.08.011_bib66","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1016\/j.jacc.2004.08.053","article-title":"Drug-induced atrial fibrillation","volume":"44","author":"van der Hooft","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jaccao.2021.08.011_bib67","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1161\/CIRCULATIONAHA.112.100560","article-title":"Cancer therapy-induced cardiac toxicity in early breast cancer: addressing the unresolved issues","volume":"126","author":"Khouri","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jaccao.2021.08.011_bib68","first-page":"1491","article-title":"Ibrutinib-associated atrial fibrillation","volume":"4","author":"Ganatra","year":"2018","journal-title":"J\u00a0Am Coll Cardiol EP"},{"key":"10.1016\/j.jaccao.2021.08.011_bib69","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0211228","article-title":"Ibrutinib increases the risk of hypertension and atrial fibrillation: systematic review and meta-analysis","volume":"14","author":"Caldeira","year":"2019","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jaccao.2021.08.011_bib70","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.3324\/haematol.2017.171041","article-title":"Characterization of atrial fibrillation adverse events reported in ibrutinib randomized controlled registration trials","volume":"102","author":"Brown","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.jaccao.2021.08.011_bib71","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.hrthm.2010.05.032","article-title":"Novel KCNA5 mutation implicates tyrosine kinase signaling in human atrial fibrillation","volume":"7","author":"Yang","year":"2010","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jaccao.2021.08.011_bib72","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1161\/CIRCULATIONAHA.120.049210","article-title":"Ibrutinib-mediated atrial fibrillation attributable to inhibition of C-terminal Src kinase","volume":"142","author":"Xiao","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jaccao.2021.08.011_bib73","doi-asserted-by":"crossref","first-page":"101432","DOI":"10.1016\/j.redox.2020.101432","article-title":"Enhanced cardiomyocyte reactive oxygen species signaling promotes ibrutinib-induced atrial fibrillation","volume":"30","author":"Yang","year":"2020","journal-title":"Redox Biol"},{"key":"10.1016\/j.jaccao.2021.08.011_bib74","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/j.jacc.2019.07.079","article-title":"Cardiovascular toxicities of immune checkpoint inhibitors: JACC review topic of the week","volume":"74","author":"Ball","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jaccao.2021.08.011_bib75","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/s41591-020-0964-7","article-title":"Myocardial infarction accelerates breast cancer via innate immune reprogramming","volume":"26","author":"Koelwyn","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.jaccao.2021.08.011_bib76","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1200\/JCO.2017.77.4414","article-title":"Association of cardiovascular risk factors with cardiac events and survival outcomes among patients with breast cancer enrolled in SWOG clinical trials","volume":"36","author":"Hershman","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jaccao.2021.08.011_bib77","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ijcard.2020.04.085","article-title":"De novo malignancy risk in patients undergoing the first percutaneous coronary intervention: a nationwide population-based cohort study","volume":"313","author":"Kwak","year":"2020","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jaccao.2021.08.011_bib78","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1161\/CIRCULATIONAHA.108.772962","article-title":"Prediction of first events of coronary heart disease and stroke with consideration of adiposity","volume":"118","author":"Wilson","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jaccao.2021.08.011_bib79","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1056\/NEJMsr1606602","article-title":"Body fatness and cancer\u2014viewpoint of the IARC working group","volume":"375","author":"Lauby-Secretan","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaccao.2021.08.011_bib80","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1056\/NEJMoa066603","article-title":"Long-term mortality after gastric bypass surgery","volume":"357","author":"Adams","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaccao.2021.08.011_bib81","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/SLA.0000000000002525","article-title":"Bariatric surgery and the risk of cancer in a large multisite cohort","volume":"269","author":"Schauer","year":"2019","journal-title":"Ann Surg"},{"key":"10.1016\/j.jaccao.2021.08.011_bib82","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1038\/ajg.2011.301","article-title":"Is diabetes mellitus an independent risk factor for colon cancer and rectal cancer?","volume":"106","author":"Yuhara","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaccao.2021.08.011_bib83","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaccao.2021.08.011_bib84","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1701719","article-title":"Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease","volume":"377","author":"Jaiswal","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaccao.2021.08.011_bib85","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1001\/jamacardio.2019.0302","article-title":"Connections between clonal hematopoiesis, cardiovascular disease, and cancer: a review","volume":"4","author":"Calvillo-Arguelles","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jaccao.2021.08.011_bib86","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jacc.2019.05.045","article-title":"Clonal hematopoiesis of indeterminate potential reshapes age-related CVD: JACC review topic of the week","volume":"74","author":"Khetarpal","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jaccao.2021.08.011_bib87","first-page":"684","article-title":"JAK2 (V617F)\u2013mediated clonal hematopoiesis accelerates pathological remodeling in murine heart failure","volume":"4","author":"Sano","year":"2019","journal-title":"J\u00a0Am Coll Cardiol Basic Trans Science"},{"key":"10.1016\/j.jaccao.2021.08.011_bib88","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1126\/science.aag1381","article-title":"Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice","volume":"355","author":"Fuster","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.jaccao.2021.08.011_bib89","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1161\/CIRCULATIONAHA.119.044362","article-title":"Genetic interleukin 6 signaling deficiency attenuates cardiovascular risk in clonal hematopoiesis","volume":"141","author":"Bick","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jaccao.2021.08.011_bib90","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.bcmd.2012.06.004","article-title":"for the French Group of Familial Myeloproliferative Disorders. Long term follow up of 93 families with myeloproliferative neoplasms: life expectancy and implications of JAK2V617F in the occurrence of complications","volume":"49","author":"Malak","year":"2012","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.jaccao.2021.08.011_bib91","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1046\/j.1365-2796.1998.00314.x","article-title":"Acute coronary disease in essential thrombocythemia and polycythemia vera","volume":"244","author":"Rossi","year":"1998","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.jaccao.2021.08.011_bib92","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1182\/blood-2009-08-238956","article-title":"Thrombosis in primary myelofibrosis: incidence and risk factors","volume":"115","author":"Barbui","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jaccao.2021.08.011_bib93","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1161\/CIRCRESAHA.118.313283","article-title":"Macrophage inflammation, erythrophagocytosis, and accelerated atherosclerosis in Jak2 (V617F) mice","volume":"123","author":"Wang","year":"2018","journal-title":"Circ Res"},{"key":"10.1016\/j.jaccao.2021.08.011_bib94","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan8292","article-title":"Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms","volume":"10","author":"Wolach","year":"2018","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jaccao.2021.08.011_bib95","doi-asserted-by":"crossref","first-page":"4359","DOI":"10.1172\/JCI90312","article-title":"JAK2-V617F promotes venous thrombosis through \u03b21\/\u03b22 integrin activation","volume":"128","author":"Edelmann","year":"2018","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jaccao.2021.08.011_bib96","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10557-020-06943-9","article-title":"Inhibition of JAK2 suppresses myelopoiesis and atherosclerosis in Apoe(-\/-) mice","volume":"34","author":"Tang","year":"2020","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.jaccao.2021.08.011_bib97","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","article-title":"Tumour-associated macrophages as treatment targets in oncology","volume":"14","author":"Mantovani","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jaccao.2021.08.011_bib98","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1182\/blood-2018-03-840629","article-title":"Detection of clonal hematopoiesis of indeterminate potential in clinical sequencing of solid tumor specimens","volume":"131","author":"Severson","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jaccao.2021.08.011_bib99","doi-asserted-by":"crossref","first-page":"5918","DOI":"10.1158\/1078-0432.CCR-18-1201","article-title":"Identification of clonal hematopoiesis mutations in solid tumor patients undergoing unpaired next-generation sequencing assays","volume":"24","author":"Coombs","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jaccao.2021.08.011_bib100","doi-asserted-by":"crossref","first-page":"e222","DOI":"10.1002\/ctm2.222","article-title":"Comprehensive next-generation profiling of clonal hematopoiesis in cancer patients using paired tumor-blood sequencing for guiding personalized therapies","volume":"10","author":"Li","year":"2020","journal-title":"Clin Transl Med"},{"key":"10.1016\/j.jaccao.2021.08.011_bib101","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.stem.2017.07.010","article-title":"Therapy-related clonal hematopoiesis in patients with non-hematologic cancers is common and associated with adverse clinical outcomes","volume":"21","author":"Coombs","year":"2017","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jaccao.2021.08.011_bib102","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa1209825","article-title":"Risk of ischemic heart disease in women after radiotherapy for breast cancer","volume":"368","author":"Darby","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaccao.2021.08.011_bib103","doi-asserted-by":"crossref","first-page":"223","DOI":"10.21037\/jtd.2020.01.52","article-title":"Heart dose and coronary artery calcification in patients receiving thoracic irradiation for lung cancer","volume":"12","author":"Yakupovich","year":"2020","journal-title":"J\u00a0Thorac Dis"},{"key":"10.1016\/j.jaccao.2021.08.011_bib104","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1161\/CIR.0b013e3182a88099","article-title":"Long-term cardiovascular toxicity in children, adolescents, and young adults who receive cancer therapy: pathophysiology, course, monitoring, management, prevention, and research directions: a scientific statement from the American Heart Association","volume":"128","author":"Lipshultz","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jaccao.2021.08.011_bib105","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1161\/CIRCULATIONAHA.115.018347","article-title":"Vascular toxicities of cancer therapies: the old and the new\u2014an evolving avenue","volume":"133","author":"Herrmann","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jaccao.2021.08.011_bib106","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1007\/s00380-011-0222-5","article-title":"Primary percutaneous coronary intervention and intravascular ultrasound imaging for coronary thrombosis after cisplatin-based chemotherapy","volume":"27","author":"Ito","year":"2012","journal-title":"Heart Vessels"},{"key":"10.1016\/j.jaccao.2021.08.011_bib107","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3109\/02841860903524396","article-title":"Risk of cardiac ischemia and arterial thromboembolic events with the angiogenesis inhibitor bevacizumab in cancer patients: a meta-analysis of randomized controlled trials","volume":"49","author":"Ranpura","year":"2010","journal-title":"Acta Oncol"},{"key":"10.1016\/j.jaccao.2021.08.011_bib108","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1016\/j.ijcard.2013.03.010","article-title":"Systemic VEGF inhibition accelerates experimental atherosclerosis and disrupts endothelial homeostasis\u2014implications for cardiovascular safety","volume":"168","author":"Winnik","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jaccao.2021.08.011_bib109","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1001\/jamaoncol.2015.5932","article-title":"Association between BCR-ABL tyrosine kinase inhibitors for chronic myeloid leukemia and cardiovascular events, major molecular response, and overall survival: a systematic review and meta-analysis","volume":"2","author":"Douxfils","year":"2016","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jaccao.2021.08.011_bib110","doi-asserted-by":"crossref","first-page":"994","DOI":"10.5551\/jat.RV17027","article-title":"Mechanism and management of cancer chemotherapy-induced atherosclerosis","volume":"25","author":"Mukai","year":"2018","journal-title":"J\u00a0Atheroscler Thromb"},{"key":"10.1016\/j.jaccao.2021.08.011_bib111","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jacc.2017.10.084","article-title":"Selective EGF-receptor inhibition in CD4(+) T cells induces anergy and limits atherosclerosis","volume":"71","author":"Zeboudj","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jaccao.2021.08.011_bib112","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ejca.2019.06.021","article-title":"Acute vascular events as a possibly related adverse event of immunotherapy: a single-institute retrospective study","volume":"120","author":"Bar","year":"2019","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jaccao.2021.08.011_bib113","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1161\/CIRCULATIONAHA.120.049981","article-title":"Association between immune checkpoint inhibitors with cardiovascular events and atherosclerotic plaque","volume":"142","author":"Drobni","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jaccao.2021.08.011_bib114","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1111\/j.1538-7836.2009.03586.x","article-title":"Platelet functions beyond hemostasis","volume":"7","author":"Smyth","year":"2009","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jaccao.2021.08.011_bib115","doi-asserted-by":"crossref","first-page":"5087","DOI":"10.1182\/blood-2006-12-027698","article-title":"The growing complexity of platelet\u00a0aggregation","volume":"109","author":"Jackson","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jaccao.2021.08.011_bib116","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1182\/blood-2003-08-2804","article-title":"Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions","volume":"103","author":"Coppinger","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jaccao.2021.08.011_bib117","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nrc2618","article-title":"Microenvironmental regulation of metastasis","volume":"9","author":"Joyce","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jaccao.2021.08.011_bib118","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMra071014","article-title":"Platelet activation and atherothrombosis","volume":"357","author":"Davi","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaccao.2021.08.011_bib119","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1182\/blood-2017-05-743187","article-title":"Cancer and platelet crosstalk: opportunities and challenges for aspirin and other antiplatelet agents","volume":"131","author":"Xu","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jaccao.2021.08.011_bib120","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/35393","article-title":"CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells","volume":"391","author":"Henn","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.jaccao.2021.08.011_bib121","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.thromres.2017.06.016","article-title":"Platelet granule release is associated with reactive oxygen species generation during platelet storage: a direct link between platelet pro-inflammatory and oxidation states","volume":"156","author":"Ghasemzadeh","year":"2017","journal-title":"Thromb Res"},{"key":"10.1016\/j.jaccao.2021.08.011_bib122","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/cvr\/cvn015","article-title":"Platelet lipoprotein interplay: trigger of foam cell formation and driver of atherosclerosis","volume":"78","author":"Siegel-Axel","year":"2008","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jaccao.2021.08.011_bib123","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1093\/eurheartj\/ehx146","article-title":"Regulation of oxidized platelet lipidome: implications for coronary artery disease","volume":"38","author":"Chatterjee","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jaccao.2021.08.011_bib124","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax0481","article-title":"Platelet regulation of myeloid suppressor of cytokine signaling 3 accelerates atherosclerosis","volume":"11","author":"Barrett","year":"2019","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jaccao.2021.08.011_bib125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025595","article-title":"Monocyte-platelet interaction induces a pro-inflammatory phenotype in circulating monocytes","volume":"6","author":"Passacquale","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jaccao.2021.08.011_bib126","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1182\/blood.2019000518","article-title":"Eosinophil-platelet interactions promote atherosclerosis and stabilize thrombosis with eosinophil extracellular traps","volume":"134","author":"Marx","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jaccao.2021.08.011_bib127","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1055\/s-0039-1692983","article-title":"Platelet-neutrophil crosstalk in atherothrombosis","volume":"119","author":"Pircher","year":"2019","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jaccao.2021.08.011_bib128","doi-asserted-by":"crossref","first-page":"5612","DOI":"10.1002\/jcb.27844","article-title":"Platelet-neutrophil interaction aggravates vascular inflammation and promotes the progression of atherosclerosis by activating the TLR4\/NF-\u03baB pathway","volume":"120","author":"Liang","year":"2019","journal-title":"J\u00a0Cell Biochem"},{"key":"10.1016\/j.jaccao.2021.08.011_bib129","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.ahj.2015.05.011","article-title":"Urinary 11-dehydro-thromboxane B2 is associated with cardiovascular events and mortality in patients with atrial fibrillation","volume":"170","author":"Pastori","year":"2015","journal-title":"Am Heart J"},{"key":"10.1016\/j.jaccao.2021.08.011_bib130","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nrc3004","article-title":"Contribution of platelets to tumour metastasis","volume":"11","author":"Gay","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jaccao.2021.08.011_bib131","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1182\/blood.2019003977","article-title":"Aspirin and antiplatelet treatments in cancer","volume":"137","author":"Tao","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jaccao.2021.08.011_bib132","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1080\/09537104.2020.1810653","article-title":"Prognostic significance of thrombocytosis in lung cancer: a systematic review and meta-analysis","volume":"32","author":"Ma","year":"2021","journal-title":"Platelets"},{"key":"10.1016\/j.jaccao.2021.08.011_bib133","first-page":"4295","article-title":"Poor prognosis significance of pretreatment thrombocytosis in patients with colorectal cancer: a meta-analysis","volume":"17","author":"Zhao","year":"2016","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.jaccao.2021.08.011_bib134","doi-asserted-by":"crossref","first-page":"8169","DOI":"10.3390\/ijms21218169","article-title":"Platelets, Thrombocytosis, and ovarian cancer prognosis: surveying the landscape of the literature","volume":"21","author":"Hufnagel","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaccao.2021.08.011_bib135","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1111\/liv.14560","article-title":"Thrombocytosis is associated with worse survival in patients with hepatocellular carcinoma","volume":"40","author":"Liu","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.jaccao.2021.08.011_bib136","doi-asserted-by":"crossref","first-page":"5177","DOI":"10.1038\/s41388-020-1357-6","article-title":"Targeting platelets for improved outcome in KRAS-driven lung adenocarcinoma","volume":"39","author":"Hyslop","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.jaccao.2021.08.011_bib137","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/jth.13604","article-title":"C-type lectin-like receptor 2 promotes hematogenous tumor metastasis and prothrombotic state in tumor-bearing mice","volume":"15","author":"Shirai","year":"2017","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jaccao.2021.08.011_bib138","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1182\/bloodadvances.2020002998","article-title":"Glioblastoma cell populations with distinct oncogenic programs release podoplanin as procoagulant extracellular vesicles","volume":"5","author":"Tawil","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.jaccao.2021.08.011_bib139","doi-asserted-by":"crossref","first-page":"7884","DOI":"10.1158\/0008-5472.CAN-09-1451","article-title":"Blockade of a chemokine, CCL2, reduces chronic colitis-associated carcinogenesis in mice","volume":"69","author":"Popivanova","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.jaccao.2021.08.011_bib140","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1080\/09537104.2018.1453059","article-title":"The pro-inflammatory role of platelets in cancer","volume":"29","author":"Olsson","year":"2018","journal-title":"Platelets"},{"key":"10.1016\/j.jaccao.2021.08.011_bib141","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1182\/blood-2011-08-376426","article-title":"Recruitment of monocytes\/macrophages by tissue factor-mediated coagulation is essential for metastatic cell survival and premetastatic niche establishment in mice","volume":"119","author":"Gil-Bernabe","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jaccao.2021.08.011_bib142","doi-asserted-by":"crossref","first-page":"9325","DOI":"10.1073\/pnas.95.16.9325","article-title":"P-selectin deficiency attenuates tumor growth and metastasis","volume":"95","author":"Kim","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaccao.2021.08.011_bib143","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41586-020-2394-6","article-title":"DNA of neutrophil extracellular traps promotes cancer metastasis via CCDC25","volume":"583","author":"Yang","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jaccao.2021.08.011_bib144","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-11-1872","article-title":"Platelet-derived MHC class I confers a pseudonormal phenotype to cancer cells that subverts the antitumor reactivity of natural killer immune cells","volume":"72","author":"Placke","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.jaccao.2021.08.011_bib145","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aai7911","article-title":"Platelets subvert T cell immunity against cancer via GARP-TGF\u03b2 axis","volume":"2","author":"Rachidi","year":"2017","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jaccao.2021.08.011_bib146","doi-asserted-by":"crossref","first-page":"19296","DOI":"10.1038\/s41598-020-76351-4","article-title":"Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors","volume":"10","author":"Zaslavsky","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaccao.2021.08.011_bib147","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrc.2017.51","article-title":"Microenvironmental regulation of tumour angiogenesis","volume":"17","author":"De Palma","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jaccao.2021.08.011_bib148","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3389\/fcvm.2017.00074","article-title":"Platelet-derived microvesicles in cardiovascular diseases","volume":"4","author":"Zaldivia","year":"2017","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jaccao.2021.08.011_bib149","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1161\/CIRCULATIONAHA.120.046308","article-title":"Dual antiplatelet therapy after percutaneous coronary intervention and drug-eluting stents: a systematic review and network meta-analysis","volume":"142","author":"Khan","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jaccao.2021.08.011_bib150","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.3390\/cancers12113215","article-title":"Antiplatelet therapy improves the prognosis of patients with hepatocellular carcinoma","volume":"12","author":"Hayashi","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jaccao.2021.08.011_bib151","first-page":"236","article-title":"The TICONC (Ticagrelor-Oncology) study","volume":"2","author":"Wright","year":"2020","journal-title":"J\u00a0Am Coll Cardiol CardioOnc"},{"key":"10.1016\/j.jaccao.2021.08.011_bib152","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s10555-017-9675-z","article-title":"Beyond COX-1: the effects of aspirin on platelet biology and potential mechanisms of chemoprevention","volume":"36","author":"Ornelas","year":"2017","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.jaccao.2021.08.011_bib153","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/S0140-6736(12)60209-8","article-title":"Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials","volume":"379","author":"Rothwell","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jaccao.2021.08.011_bib154","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S1470-2045(12)70112-2","article-title":"Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials","volume":"13","author":"Algra","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jaccao.2021.08.011_bib155","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/jnci\/djk132","article-title":"A\u00a0large cohort study of long-term daily use of adult-strength aspirin and cancer incidence","volume":"99","author":"Jacobs","year":"2007","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.jaccao.2021.08.011_bib156","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/S0140-6736(11)61720-0","article-title":"Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials","volume":"379","author":"Rothwell","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jaccao.2021.08.011_bib157","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1007\/s00432-019-02932-0","article-title":"Safety and efficacy of aspirin for primary prevention of cancer: a meta-analysis of randomized controlled trials","volume":"145","author":"Haykal","year":"2019","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"issue":"3","key":"10.1016\/j.jaccao.2021.08.011_bib158","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/jnci\/djaa114","article-title":"Effect of aspirin on cancer incidence and mortality in older adults","volume":"113","author":"McNeil","year":"2021","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.jaccao.2021.08.011_bib159","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.clpt.2005.08.002","article-title":"Anti-inflammatory effects of clopidogrel intake in renal transplant patients: effects on platelet-leukocyte interactions, platelet CD40 ligand expression, and proinflammatory biomarkers","volume":"78","author":"Graff","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jaccao.2021.08.011_bib160","doi-asserted-by":"crossref","first-page":"E2165","DOI":"10.1073\/pnas.1209182109","article-title":"Antiplatelet therapy prevents hepatocellular carcinoma and improves survival in a mouse model of chronic hepatitis B","volume":"109","author":"Sitia","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaccao.2021.08.011_bib161","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1182\/blood-2017-02-769893","article-title":"Role of ADP receptors on platelets in the growth of ovarian cancer","volume":"130","author":"Cho","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jaccao.2021.08.011_bib162","doi-asserted-by":"crossref","first-page":"42733","DOI":"10.18632\/oncotarget.5811","article-title":"Identification of a novel platelet antagonist that binds to CLEC-2 and suppresses podoplanin-induced platelet aggregation and cancer metastasis","volume":"6","author":"Chang","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jaccao.2021.08.011_bib163","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1016\/j.thromres.2012.01.003","article-title":"Podoplanin expression in advanced atherosclerotic lesions of human aortas","volume":"129","author":"Hatakeyama","year":"2012","journal-title":"Thromb Res"},{"key":"10.1016\/j.jaccao.2021.08.011_bib164","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11684-019-0692-x","article-title":"Plasma soluble C-type lectin-like receptor-2 is associated with the risk of coronary artery disease","volume":"14","author":"Fei","year":"2020","journal-title":"Front Med"},{"key":"10.1016\/j.jaccao.2021.08.011_bib165","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1111\/ene.13984","article-title":"Plasma C-type lectin-like receptor 2 as a predictor of death and vascular events in patients with acute ischemic stroke","volume":"26","author":"Wu","year":"2019","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jaccao.2021.08.011_bib166","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1182\/blood-2017-04-777417","article-title":"Upregulation of lysyl oxidase and adhesion to collagen of human megakaryocytes and platelets in primary myelofibrosis","volume":"130","author":"Abbonante","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jaccao.2021.08.011_bib167","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3390\/cancers13030491","article-title":"Targeting lysyl oxidase family meditated matrix cross-linking as an anti-stromal therapy in solid tumours","volume":"13","author":"Setargew","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jaccao.2021.08.011_bib168","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/cvr\/cvn102","article-title":"Regulation of lysyl oxidase in vascular cells: lysyl oxidase as a new player in cardiovascular diseases","volume":"79","author":"Rodriguez","year":"2008","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jaccao.2021.08.011_bib169","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1161\/01.ATV.1.4.287","article-title":"Changes in aortic lysyl oxidase activity in diet-induced atherosclerosis in the rabbit","volume":"1","author":"Kagan","year":"1981","journal-title":"Arteriosclerosis"},{"key":"10.1016\/j.jaccao.2021.08.011_bib170","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jvs.2004.02.028","article-title":"Lysyl oxidase expression in a rat model of arterial balloon injury","volume":"40","author":"Nuthakki","year":"2004","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jaccao.2021.08.011_bib171","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1182\/blood-2015-02-629667","article-title":"Lysyl oxidase is associated with increased thrombosis and platelet reactivity","volume":"127","author":"Matsuura","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jaccao.2021.08.011_bib172","doi-asserted-by":"crossref","first-page":"5107","DOI":"10.1038\/s41598-021-84492-3","article-title":"Lysyl oxidase engineered lipid nanovesicles for the treatment of triple negative breast cancer","volume":"11","author":"De Vita","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaccao.2021.08.011_bib173","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1038\/s41467-020-16199-4","article-title":"Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer","volume":"11","author":"Saatci","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaccao.2021.08.011_bib174","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s12185-019-02751-6","article-title":"Novel lysyl oxidase inhibitors attenuate hallmarks of primary myelofibrosis in mice","volume":"110","author":"Leiva","year":"2019","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jaccao.2021.08.011_bib175","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1182\/blood-2013-04-460121","article-title":"Epidemiology of cancer-associated venous thrombosis","volume":"122","author":"Timp","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jaccao.2021.08.011_bib176","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1001\/jama.293.6.715","article-title":"Malignancies, prothrombotic mutations, and the risk of venous thrombosis","volume":"293","author":"Blom","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jaccao.2021.08.011_bib177","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1056\/NEJM200012213432504","article-title":"Prognosis of cancers associated with venous thromboembolism","volume":"343","author":"Sorensen","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaccao.2021.08.011_bib178","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1182\/blood-2002-01-0108","article-title":"Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis","volume":"100","author":"Prandoni","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jaccao.2021.08.011_bib179","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/jth.14468","article-title":"Periprocedural interruption of anticoagulation in patients with cancer-associated venous thromboembolism: an analysis of thrombotic and bleeding outcomes","volume":"17","author":"Shaw","year":"2019","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jaccao.2021.08.011_bib180","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/ajh.23122","article-title":"Cancer patients requiring interruption of long-term warfarin because of surgery or chemotherapy induced thrombocytopenia: the use of fixed sub-therapeutic doses of low-molecular weight heparin","volume":"87","author":"Saccullo","year":"2012","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jaccao.2021.08.011_bib181","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.3390\/cancers12071958","article-title":"Impact of tumor genomic mutations on thrombotic risk in cancer patients","volume":"12","author":"Leiva","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.jaccao.2021.08.011_bib182","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1111\/jth.15272","article-title":"Venous thromboembolism incidence and risk assessment in lung cancer patients treated with immune checkpoint inhibitors","volume":"19","author":"Icht","year":"2021","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jaccao.2021.08.011_bib183","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1002\/ijc.33179","article-title":"Cancer-specific ischemic complications in elderly patients with atrial fibrillation: data from the prospective ATHERO-AF study","volume":"147","author":"Pastori","year":"2020","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jaccao.2021.08.011_bib184","doi-asserted-by":"crossref","first-page":"104560","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.104560","article-title":"Risk of ischemic stroke and major bleeding in patients with atrial fibrillation and cancer","volume":"29","author":"Aspberg","year":"2020","journal-title":"J\u00a0Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.jaccao.2021.08.011_bib185","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1055\/s-0040-1708484","article-title":"The effect of chemotherapy on stroke risk in cancer patients","volume":"120","author":"Kitano","year":"2020","journal-title":"Thromb Haemost"},{"issue":"12","key":"10.1016\/j.jaccao.2021.08.011_bib186","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1002\/cncr.33470","article-title":"Thromboembolism, mortality, and bleeding in 2,435,541 atrial fibrillation patients with and without cancer: a nationwide cohort study","volume":"127","author":"Pastori","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.jaccao.2021.08.011_bib187","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1177\/2047487318759858","article-title":"CHA2DS2-VASc score and risk of thromboembolism and bleeding in patients with atrial fibrillation and recent cancer","volume":"25","author":"D\u2019Souza","year":"2018","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jaccao.2021.08.011_bib188","doi-asserted-by":"crossref","DOI":"10.1177\/1753944719860676","article-title":"Predicting outcomes in patients with cancer and atrial fibrillation","volume":"13","author":"Gutierrez","year":"2019","journal-title":"Ther Adv Cardiovasc Dis"},{"issue":"suppl 1","key":"10.1016\/j.jaccao.2021.08.011_bib189","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1016\/j.thromres.2018.01.036","article-title":"Risk prediction of cancer-associated thrombosis: Appraising the first decade and developing the future","volume":"164","author":"Khorana","year":"2018","journal-title":"Thromb Res"},{"key":"10.1016\/j.jaccao.2021.08.011_bib190","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.jtho.2020.04.033","article-title":"Impact of ALK rearrangement on venous and arterial thrombotic risk in NSCLC","volume":"15","author":"Al-Samkari","year":"2020","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jaccao.2021.08.011_bib191","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1055\/s-0038-1667001","article-title":"Clinical impact of bleeding in cancer-associated venous thromboembolism: results from the Hokusai VTE Cancer Study","volume":"118","author":"Kraaijpoel","year":"2018","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jaccao.2021.08.011_bib192","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/eurheartj\/ehaa1032","article-title":"Percutaneous coronary intervention in patients with cancer and readmissions within 90\u00a0days for acute myocardial infarction and bleeding in the USA","volume":"42","author":"Kwok","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jaccao.2021.08.011_bib193","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1093\/eurheartj\/ehz851","article-title":"Acute myocardial infarction treatments and outcomes in 6.5 million patients with a current or historical diagnosis of cancer in the USA","volume":"41","author":"Bharadwaj","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jaccao.2021.08.011_bib194","first-page":"631","article-title":"Prevalence and outcome of patients with cancer and acute coronary syndrome undergoing percutaneous coronary intervention: a BleeMACS substudy","volume":"7","author":"Iannaccone","year":"2018","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"issue":"2","key":"10.1016\/j.jaccao.2021.08.011_bib195","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1536\/ihj.20-452","article-title":"The effect of a cancer history on patients with acute myocardial infarction after percutaneous coronary intervention","volume":"62","author":"Takeuchi","year":"2021","journal-title":"Int Heart J"},{"issue":"8","key":"10.1016\/j.jaccao.2021.08.011_bib196","first-page":"829","article-title":"Effect of primary percutaneous coronary intervention on in-hospital outcomes among active cancer patients presenting with ST-elevation myocardial infarction: a propensity score matching analysis","volume":"10","author":"Mohamed","year":"2021","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"issue":"9","key":"10.1016\/j.jaccao.2021.08.011_bib197","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1007\/s00380-021-01817-y","article-title":"Temporal trends in short and long-term outcomes after percutaneous coronary interventions among cancer patients","volume":"36","author":"Nardi Agmon","year":"2021","journal-title":"Heart Vessels"},{"key":"10.1016\/j.jaccao.2021.08.011_bib198","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijcard.2020.04.050","article-title":"Acute myocardial infarction in a high-risk cancer population: outcomes following conservative versus invasive management","volume":"313","author":"Balanescu","year":"2020","journal-title":"Int J Cardiol"}],"container-title":["JACC: CardioOncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666087321002532?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666087321002532?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T18:54:57Z","timestamp":1762973697000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666087321002532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":198,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S2666087321002532"],"URL":"https:\/\/doi.org\/10.1016\/j.jaccao.2021.08.011","relation":{},"ISSN":["2666-0873"],"issn-type":[{"value":"2666-0873","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Common Pathophysiology in Cancer, Atrial Fibrillation, Atherosclerosis, and Thrombosis","name":"articletitle","label":"Article Title"},{"value":"JACC: CardioOncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaccao.2021.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}